GENNIEFY
Market News
Latest financial news and analysis from global markets
LULU
Telsey Advisory Keeps a Market Perform Rating on lululemon athletica inc. (LULU)
lululemon athletica inc. (NASDAQ:LULU) is one of the 15 Best Apparel Stocks to Buy in 2026. On March 18, 2026, Telsey Advisory analyst Dana Telsey decreased lululemon athletica inc. (NASDAQ:LULU)’s price objective to $175 from $215 while keeping a Market Perform rating. The firm noted a weaker Q1 forecast and a high-end annual guide that […]
NKE
HSBC Reduces to Hold from Buy on NIKE, Inc. (NKE)
NIKE, Inc. (NYSE:NKE) is one of the 15 Best Apparel Stocks to Buy in 2026. On April 13, 2026, HSBC analyst Erwan Rambourg reduced NIKE, Inc. (NYSE:NKE) to Hold from Buy, lowering the price objective to $48 from $90, citing limited visibility and ongoing difficulties in Converse, China, EMEA, and sportswear. On April 10, 2026, […]
MS
Morgan Stanley Retains an Equal Weight Rating on FIGS, Inc. (FIGS)
FIGS, Inc. (NYSE:FIGS) is one of the 15 Best Apparel Stocks to Buy in 2026. On April 13, 2026, Morgan Stanley boosted FIGS, Inc. (NYSE:FIGS)’s price objective to $15 from $8 while retaining an Equal Weight rating. The firm noted improved fundamentals led by sharper execution. It also pointed out that the company has already […]
MSFT
Why I Can’t Stop Buying Nvidia Stock
NVIDIA Corporation (NASDAQ:NVDA) continues to be a compelling case study in accelerating growth at scale. Every time analysts suggest the story is priced in, the company prints another quarter that makes the previous one look modest. Here are three reasons I can’t stop buying the stock. Reason 1: The Growth Trajectory Keeps Accelerating, Not Decelerating ... Why I Can’t Stop Buying Nvidia Stock
NVDA
Why I Can’t Stop Buying Nvidia Stock
NVIDIA Corporation (NASDAQ:NVDA) continues to be a compelling case study in accelerating growth at scale. Every time analysts suggest the story is priced in, the company prints another quarter that makes the previous one look modest. Here are three reasons I can’t stop buying the stock. Reason 1: The Growth Trajectory Keeps Accelerating, Not Decelerating ... Why I Can’t Stop Buying Nvidia Stock
ORCL
Why I Can’t Stop Buying Nvidia Stock
NVIDIA Corporation (NASDAQ:NVDA) continues to be a compelling case study in accelerating growth at scale. Every time analysts suggest the story is priced in, the company prints another quarter that makes the previous one look modest. Here are three reasons I can’t stop buying the stock. Reason 1: The Growth Trajectory Keeps Accelerating, Not Decelerating ... Why I Can’t Stop Buying Nvidia Stock
MSFT
Stellantis, Microsoft unveil five-year AI and cybersecurity partnership
Stellantis NV (NYSE:STLA, EPA:STLA) and Microsoft Corp (NASDAQ:MSFT) have announced a five-year strategic collaboration aimed at accelerating Stellantis’ digital transformation through artificial intelligence, cybersecurity and cloud technologies. The partnership expands on an existing...
BAC
Ciena stock gains as BofA sees a ’significant cloud growth opportunity ahead’
Investing.com -- Ciena Corporation shares are trading around 1.1% higher on Thursday after Bank of America raised its price target on the stock to $550 from $355, reiterating a Buy rating on the optical networking specialist.
PLTR
Did ARK’s Buying, Trump’s Praise and AIP Adoption Just Recast Palantir Technologies’ (PLTR) Investment Narrative?
In recent days, Palantir Technologies has drawn fresh attention as ARK Invest increased its holdings, President Donald Trump publicly praised its defense-focused AI platforms, and the company highlighted rapid adoption of its Artificial Intelligence Platform across U.S. commercial and government customers. This mix of high-profile investor support, political endorsement, and expanding real-world AI deployments is reinforcing Palantir’s image as critical infrastructure for military and...
ABT
Abbott Laboratories Q1 Earnings Call Highlights
Abbott Laboratories (NYSE:ABT) reported first-quarter 2026 results that management said were “aligned with our expectations for the start of the year,” as the company absorbed weaker respiratory testing demand and earlier-than-planned financing costs tied to its newly closed acquisition of Exact Sci
MRNA
What Moderna (MRNA)'s Expedited Flu Vaccine Review And Institutional Support Means For Shareholders
Moderna, Inc. recently participated in the 5th LNP Formulation & Process Development Summit in Boston and scheduled a May 1, 2026 webcast to discuss its first-quarter 2026 results and corporate update, while its flu vaccine remains under expedited FDA review with a decision expected in August. Investor attention has been reinforced by this accelerated regulatory process for Moderna’s flu candidate and by increased positions from large institutional shareholders such as Fidelity and BNP...
BTCUSDT
$12 Trillion US Giant Charles Schwab Launches Spot Crypto Trading
Charles Schwab launches spot Bitcoin and Ethereum trading at 75 bps, challenging Robinhood and Coinbase retail market turf.